Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
A Phase I/II, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Twice Daily Oral Midostaurin and to Evaluate the Preliminary Clinical and Pharmacodynamic Response in Pediatric Patients With Relapsed or Refractory Leukemia
Status: Enrolling
Updated:  11/18/2015
Seattle Children's Hospital CPKC412A2114
mi
from
Seattle, WA
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
A Phase I/II, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Twice Daily Oral Midostaurin and to Evaluate the Preliminary Clinical and Pharmacodynamic Response in Pediatric Patients With Relapsed or Refractory Leukemia
Status: Enrolling
Updated: 11/18/2015
Seattle Children's Hospital CPKC412A2114
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
A Phase I/II, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Twice Daily Oral Midostaurin and to Evaluate the Preliminary Clinical and Pharmacodynamic Response in Pediatric Patients With Relapsed or Refractory Leukemia
Status: Enrolling
Updated:  11/18/2015
Novartis Investigative Site
mi
from
Paris Cedex 19,
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
A Phase I/II, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Twice Daily Oral Midostaurin and to Evaluate the Preliminary Clinical and Pharmacodynamic Response in Pediatric Patients With Relapsed or Refractory Leukemia
Status: Enrolling
Updated: 11/18/2015
Novartis Investigative Site
mi
from
Paris Cedex 19,
Click here to add this to my saved trials
Geriatric Assessments in Senior Adults With Multiple Myeloma
Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma
Status: Enrolling
Updated:  11/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Geriatric Assessments in Senior Adults With Multiple Myeloma
Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma
Status: Enrolling
Updated: 11/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/19/2015
Duke University
mi
from
Durham, NC
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/19/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/19/2015
Medical University of South Carolina
mi
from
Charleston, SC
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/19/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens National Medical Center
mi
from
Washington,
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Dana Farber
mi
from
Boston, MA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
St. Jude
mi
from
Memphis, TN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
St. Jude
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Vanderbilt Children's Hospital
mi
from
Nashville, TN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Primary Children's
mi
from
Salt Lake City, UT
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Primary Children's
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Seattle Children's Hospital
mi
from
Seattle, WA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
University of Miami Cancer Center
mi
from
Miami, FL
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
University of Miami Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
New York Univ. Medical Center
mi
from
New York, NY
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
Treatment Protocol: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Using Conditioning Regimen Without Radiation
Status: Enrolling
Updated:  11/20/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
Treatment Protocol: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Using Conditioning Regimen Without Radiation
Status: Enrolling
Updated: 11/20/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
Treatment Protocol: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Using Conditioning Regimen Without Radiation
Status: Enrolling
Updated:  11/20/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
Treatment Protocol: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Using Conditioning Regimen Without Radiation
Status: Enrolling
Updated: 11/20/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Miller Children's Hospital
mi
from
Long Beach, CA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Oakland Children's Hospital
mi
from
Oakland, CA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Oakland Children's Hospital
mi
from
Oakland, CA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Stanford University Medical Center
mi
from
Palo Alto, CA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
The Children's Hospital, University of Colorado
mi
from
Aurora, CO
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
The Children's Hospital, University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Childrens National Medical Center
mi
from
Washington,
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Childrens Memorial
mi
from
Chicago, IL
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Childrens Memorial
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Johns Hopkins University
mi
from
Baltimore, MD
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Dana Farber
mi
from
Boston, MA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
University of Minnesota Children's Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Memorial Sloan-Kettering
mi
from
New York, NY
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Memorial Sloan-Kettering
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Oregon Health and Science University
mi
from
Portland, OR
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated:  11/22/2015
St. Jude
mi
from
Memphis, TN
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)
Status: Enrolling
Updated: 11/22/2015
St. Jude
mi
from
Memphis, TN
Click here to add this to my saved trials